Minghui Pharmaceutical (Shanghai) LTD
1 clinical trials · Sponsor
◉ Watch Minghui Pharmaceutical (Shanghai) LTD
| Record | Firm | Date |
|---|---|---|
| This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies (NCT04689308) | Minghui Pharmaceutical (Shanghai) LTD | 2021-01-07 |
Track Minghui Pharmaceutical (Shanghai) LTD automatically
Every clearance here is in the API, with alerts when new ones post.